Meet Wall Street’s Biggest Netflix Bear
Netflix is set to report its most recent quarterly results after the close, and while there are many analysts cheering the stock on, one analyst expects Netflix to collapse.
All Work
Chris Lange
What to Expect From Goldman Sachs in Q2
The Goldman Sachs Group, Inc. (NYSE: GS) is scheduled to release its second quarter earnings report before the markets open on Tuesday. Thomson Reuters has consensus estimates calling for $4.66 in earnings per share…
What to Expect When Johnson & Johnson Reports Tuesday Morning
Johnson & Johnson is set to report its second-quarter financial results before the markets open on Tuesday.
Why Tonix Pharmaceuticals Is Winning Big on Monday
Tonix Pharmaceuticals saw its shares make a solid gain to start off the week after the company announced an update from the FDA regarding its Alzheimer’s agitation treatment.
What to Expect When Netflix Reports After the Close
Netflix is scheduled to release its second-quarter financial results after the markets close on Monday.
Focus Financial Partners Closes in on IPO
Focus Financial Partners expects to price more than 16 million shares to result in an initial public offering valued up to more than $727 million.
Netflix, Bank of America, Morgan Stanley and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Bank of America, Philip Morris and some of the other top companies reporting their latest results in the coming week.
Microsoft, Goldman Sachs, IBM and More Dow Stocks to Watch This Week
What to expect from upcoming earnings reports from American Express, Johnson & Johnson, Microsoft and other Dow components.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a relatively positive day for the broad U.S. markets, with all the major averages closing the week with gains. Crude oil was marginally up to close out the week. The S&P 500…
FDA Warns of Potential Hoax Letters
The FDA issued a warning early on Friday that consumers should be on the lookout for criminals forging FDA warning letters.
Will Acceleron Pharma Momentum Continue After New FDA Nod?
Acceleron Pharma shares dipped on Friday after the company provided an update on an orphan drug designation from the FDA.
Citibank Just Can’t Catch a Break in Q2
Citigroup reported mixed second-quarter results before the markets opened on Friday and shares retreated afterward.
Why Wells Fargo Earnings Came Up Short
Wells Fargo released mixed second-quarter financial results before the markets opened on Friday.
Victoria’s Secret Finds Sex Doesn’t Sell
Victoria’s Secret is finding out the hard way that sex isn’t selling, at least not this summer. Its June sales were not up to par.
How Zogenix Is Winning Big With Late-Stage Seizure Study
Zogenix shares made a solid gain on Thursday after the company announced positive results from its late-stage seizure trial.
Why 2018 Isn’t Getting Any Better for L Brands
L Brands shares dropped on Thursday after the company provided an update on its summer sales.
Are Short Sellers Signaling Optimism in Social Media Stocks?
The June 29 short interest data have been compared with the previous report. Short interest in most of these selected social media stocks decreased for this settlement date.
Rising Oil Prices Intimidate Short Sellers
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected big oil stocks decreased.
Is Falling Short Interest in Banks a Good Sign Ahead of Earnings?
The June 29 short interest data have been compared with the previous figures, and short interest in these selected big bank stocks was lower.
Where Did Major Pharma Short Sellers Go?
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.